Fig. 1From: Neoadjuvant immunochemotherapy for pulmonary large-cell neuroendocrine carcinoma: case reportDisease evolution and treatment timeline under neoadjuvant immunochemotherapy. (A) The timeline therapy administration from the episode of treatment. PR, partial response; MPR, major pathological remission. (B) Computed tomography scan showed dynamic changes of lesions in radiology and revealed a partial response of disease after 2 cycles of immunochemotherapyBack to article page